Meta-Analysis on the Clinical Outcomes With Polypills for Cardiovascular Disease Prevention
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference35 articles.
1. Demographic and epidemiologic drivers of global cardiovascular mortality;Roth;N Engl J Med,2015
2. Global burden of cardiovascular diseases and risks collaboration, 1990 to 2021;Lindstrom;J Am Coll Cardiol,2022
3. Hypertension and cardiovascular disease: contributions of the Framingham Heart Study;Franklin;Glob Heart,2013
4. Association between circulating oxidized LDL and atherosclerotic cardiovascular disease: a meta-analysis of observational studies;Gao;Can J Cardiol,2017
5. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis [published correction appears in JAMA 2011;305:1862];Thompson;JAMA,2011
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in Primordial, Primary, and Secondary Prevention of Stroke in Diverse Populations;Stroke;2024-09
2. Effectiveness of polypill for primary and secondary prevention of cardiovascular disease: a pragmatic cluster-randomised controlled trial (PolyPars);Heart;2024-03-14
3. Efficacy and Safety of a Polypill to Reduce Cardiovascular Events: A Review of Clinical Trials;Journal of Cardiovascular Pharmacology;2024-01
4. Upfront Combination of Statin and Ezetimibe for Patients With Acute Coronary Syndrome: Time for a New Approach?;Journal of the American Heart Association;2023-09-19
5. One Pill for Everyone? Twenty Years of Polypill for Cardiovascular Disease;The American Journal of Cardiology;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3